[go: up one dir, main page]

BRPI0407438A - Sistema terapêutico compreendendo amoxicilina e ácido clavulânico - Google Patents

Sistema terapêutico compreendendo amoxicilina e ácido clavulânico

Info

Publication number
BRPI0407438A
BRPI0407438A BR0407438-6A BRPI0407438A BRPI0407438A BR PI0407438 A BRPI0407438 A BR PI0407438A BR PI0407438 A BRPI0407438 A BR PI0407438A BR PI0407438 A BRPI0407438 A BR PI0407438A
Authority
BR
Brazil
Prior art keywords
amoxicillin
clavulanic acid
therapeutic system
dosage
pharmaceutical composition
Prior art date
Application number
BR0407438-6A
Other languages
English (en)
Inventor
Janez Kerc
Jerneja Opara
Maja Jenko Osel
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200300044A external-priority patent/SI21401A/sl
Priority claimed from SI200300245A external-priority patent/SI21601A/sl
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of BRPI0407438A publication Critical patent/BRPI0407438A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

"SISTEMA TERAPêUTICO COMPREENDENDO AMOXICILINA E áCIDO CLAVULâNICO". A presente invenção refere-se a novo sistema terapêutico para a administração uma ou duas vezes diariamente de amoxicilina e ácido clavulânico. Uma parte da dosagem é provida por pelo menos uma composição farmacêutica de amoxicilina/ácido clavulânico de liberação imediata, e outra parte da dosagem é provida por pelo menos uma composição farmacêutica de amoxicilina gastrorretentiva de liberação atrasada ou sustentada.
BR0407438-6A 2003-02-21 2004-02-20 Sistema terapêutico compreendendo amoxicilina e ácido clavulânico BRPI0407438A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200300044A SI21401A (sl) 2003-02-21 2003-02-21 Terapevtski sistem
SI200300245A SI21601A (sl) 2003-09-24 2003-09-24 Terapevtski sistem
PCT/SI2004/000010 WO2004073695A1 (en) 2003-02-21 2004-02-20 Therapeutic system comprising amoxicillin and clavulanic acid

Publications (1)

Publication Number Publication Date
BRPI0407438A true BRPI0407438A (pt) 2006-02-07

Family

ID=32911559

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0407438-6A BRPI0407438A (pt) 2003-02-21 2004-02-20 Sistema terapêutico compreendendo amoxicilina e ácido clavulânico

Country Status (11)

Country Link
US (1) US20060121106A1 (pt)
EP (1) EP1596841B1 (pt)
AT (1) ATE410152T1 (pt)
BR (1) BRPI0407438A (pt)
CA (1) CA2516327C (pt)
DE (1) DE602004016963D1 (pt)
EA (1) EA011215B1 (pt)
MX (1) MXPA05008843A (pt)
PL (1) PL213804B1 (pt)
SI (1) SI1596841T1 (pt)
WO (1) WO2004073695A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527807B2 (en) 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
EP1681050A1 (en) * 2005-01-13 2006-07-19 Strides Arcolab Limited Dispersible sustained release pharmaceutical compositions
EP2974718A1 (en) 2005-04-29 2016-01-20 Cubist Pharmaceuticals, Inc. Therapeutic compositions
US8357394B2 (en) * 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
AU2006321782B2 (en) * 2005-12-08 2012-11-29 Shionogi, Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2008029417A2 (en) 2006-09-04 2008-03-13 Matrix Laboratories Limited Pharmaceutical formulation for use in hiv therapy
CA2735934C (en) 2008-09-05 2014-01-07 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
WO2011104652A2 (en) * 2010-02-24 2011-09-01 Pfizer Inc. Veterinary compositions
MX2014008375A (es) * 2012-01-10 2017-07-27 Spector Michael Formulaciones pedriaticas de supspension oral de amoxicilina y clauvulanato de potasio y metodo para su uso.
US9358204B2 (en) * 2012-02-08 2016-06-07 Supernus Pharmaceuticals, Inc. Formulations of viloxazine
US20140279169A1 (en) * 2013-03-15 2014-09-18 Toyota Motor Sales, U.S.A., Inc. Method for generating vehicle repair estimate reports based on predictive estimating
EP3125873B1 (en) 2014-04-04 2020-06-03 Pharmaquest International Center, LLC Disintegrating monolithic modified release tablets containing quadri-layer extended release granules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (pt) * 1974-03-12 1980-04-02
US4083956A (en) * 1976-04-29 1978-04-11 The Procter & Gamble Company Anhydrous antiperspirant creams
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
JP2959423B2 (ja) * 1994-12-01 1999-10-06 シオノギクオリカプス株式会社 カプセル用皮膜組成物
EP1330236A2 (en) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin

Also Published As

Publication number Publication date
CA2516327C (en) 2012-04-17
CA2516327A1 (en) 2004-09-02
ATE410152T1 (de) 2008-10-15
EP1596841A1 (en) 2005-11-23
EA011215B1 (ru) 2009-02-27
WO2004073695A1 (en) 2004-09-02
US20060121106A1 (en) 2006-06-08
EP1596841B1 (en) 2008-10-08
MXPA05008843A (es) 2005-10-18
EA200501223A1 (ru) 2006-04-28
SI1596841T1 (sl) 2009-06-30
PL213804B1 (pl) 2013-05-31
PL377683A1 (pl) 2006-02-06
DE602004016963D1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
BRPI0518266B8 (pt) medicamento oral de liberação modificada de pelo menos um princípio ativo sob a forma multimicrocapsular
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
UA41346C2 (uk) Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
BR9908488A (pt) Composição farmacêutica de topiramato
DK1256343T3 (da) Flibanserin til behandlingen af extrapyramidale bevægelseslidelser
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
BRPI0407438A (pt) Sistema terapêutico compreendendo amoxicilina e ácido clavulânico
BR9803300A (pt) Formulação farmacêutica.
NO20022442D0 (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
KR970025615A (ko) 암 전이 억제제
EP1781277A4 (en) COMBINED COMPOSITION
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
WO2005004915A3 (en) Compositions comprising meloxicam
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
HUP0400115A2 (hu) Gyógyászati készítmény fulvesztrant intramuszkuláris beadására
DE60124144D1 (de) Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
BR0311642A (pt) Formulação de divalproex de sódio de liberação aumentada
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
BRPI0713278A2 (pt) agente profilÁtico ou terapÊutico para doenÇa viral

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 9/52, 9/36; A61P 31/00

Ipc: A61K 9/52 (2011.01), A61K 9/36 (2011.01), A61P 31/

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.